Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 23:1231–1251. https://doi.org/10.1093/neuonc/noab106

Article  CAS  PubMed  PubMed Central  Google Scholar 

Weller M, van den Bent M, Preusser M et al (2021) EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol 18:170–186. https://doi.org/10.1038/s41571-020-00447-z

Article  PubMed  Google Scholar 

Mohile NA, Messersmith H, Gatson NT et al (2022) Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline. J Clin Oncol 40:403–426. https://doi.org/10.1200/JCO.21.02036

Article  CAS  PubMed  Google Scholar 

Miller JJ, Gonzalez Castro LN, McBrayer S et al (2023) Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions. Neuro Oncol 25:4–25. https://doi.org/10.1093/neuonc/noac207

Article  CAS  PubMed  PubMed Central  Google Scholar 

Halasz LM, Attia A, Bradfield L et al (2022) Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An ASTRO Clinical Practice Guideline. Pract Radiat Oncol 12:370–386. https://doi.org/10.1016/j.prro.2022.05.004

Article  PubMed  Google Scholar 

Pallud J (2025) The time has come for an integrated and multiscale grading system for oligodendrogliomas IDH -mutant and 1p/19q co-deleted mixing imaging and histomolecular parameters. Neuro Oncol 27:1128–1129. https://doi.org/10.1093/neuonc/noaf022

Article  PubMed  PubMed Central  Google Scholar 

Elia A, Roux A, Trancart B et al (2024) Watch-and-wait approach versus adjuvant treatment after radical awake resection in selected adult-type grade 3 gliomas, isocitrate dehydrogenase mutant: A case-matched cohort. Neuro-Oncology Adv 6:vdae189. https://doi.org/10.1093/noajnl/vdae189

Article  Google Scholar 

Ryan D, Sugita M, Broadwater G et al (2025) Frequency, risk factors, and outcomes of strokes in patients with primary glioma after cranial radiation therapy. Neurology 105. https://doi.org/10.1212/WNL.0000000000213902

Nagtegaal SHJ, David S, van Grinsven EE et al (2021) Morphological changes after cranial fractionated photon radiotherapy: Localized loss of white matter and grey matter volume with increasing dose. Clin Transl Radiat Oncol 31:14–20. https://doi.org/10.1016/j.ctro.2021.08.010

Article  CAS  PubMed  PubMed Central  Google Scholar 

Raschke F, Witzmann K, Seidlitz A et al (2022) Time- and dose-dependent volume decreases in subcortical grey matter structures of glioma patients after radio(chemo)therapy. Clin Transl Radiat Oncol 36:99–105. https://doi.org/10.1016/j.ctro.2022.07.003

Article  CAS  PubMed  PubMed Central  Google Scholar 

Douw L, Klein M, Fagel SS et al (2009) Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up. Lancet Neurol 8:810–818. https://doi.org/10.1016/S1474-4422(09)70204-2

Article  PubMed  Google Scholar 

Zer A, Pond GR, Razak ARA et al (2017) Association of neurocognitive deficits with radiotherapy or chemoradiotherapy for patients with head and neck cancer. JAMA Otolaryngol Neck Surg. https://doi.org/10.1001/jamaoto.2017.2235

Pazzaglia S, Briganti G, Mancuso M, Saran A (2020) Neurocognitive decline following radiotherapy: mechanisms and therapeutic implications. Cancers (Basel) 12. https://doi.org/10.3390/cancers12010146

Bitterlich C, Vordermark D (2017) Analysis of health-related quality of life in patients with brain tumors prior and subsequent to radiotherapy. Oncol Lett 14:1841–1846. https://doi.org/10.3892/ol.2017.6310

Article  PubMed  PubMed Central  Google Scholar 

Lawrie TA, Gillespie D, Dowswell T et al (2019) Long-term neurocognitive and other side effects of radiotherapy, with or without chemotherapy, for glioma. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD013047.pub2

Article  PubMed  PubMed Central  Google Scholar 

Surma-aho O, Niemela M, Vilkki J et al (2001) Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients. Neurology 56:1285–1290. https://doi.org/10.1212/WNL.56.10.1285

Article  CAS  PubMed  Google Scholar 

Wehming FM, Wiese B, Nakamura M et al (2012) Malignant glioma grade 3 and 4: How relevant is timing of radiotherapy? Clin Neurol Neurosurg 114:617–621. https://doi.org/10.1016/j.clineuro.2011.12.024

Article  PubMed  Google Scholar 

Nitta M, Muragaki Y, Maruyama T et al (2015) Proposed therapeutic strategy for adult low-grade glioma based on aggressive tumor resection. Neurosurg Focus 38:E7. https://doi.org/10.3171/2014.10.FOCUS14651

Article  PubMed  Google Scholar 

Mair MJ, Leibetseder A, Heller G et al (2022) Early Postoperative Treatment versus Initial Observation in CNS WHO Grade 2 and 3 Oligodendroglioma: Clinical Outcomes and DNA Methylation Patterns. Clin Cancer Res 28:4565–4573. https://doi.org/10.1158/1078-0432.CCR-22-1133

Article  CAS  PubMed  Google Scholar 

Pallud J, Zanello M, Moiraghi A et al (2021) Surgery of Insular Diffuse Gliomas—Part 1. Neurosurgery 89:565–578. https://doi.org/10.1093/neuros/nyab254

Article  PubMed  Google Scholar 

Pallud J, Rigaux-Viode O, Corns R et al (2017) Direct electrical bipolar electrostimulation for functional cortical and subcortical cerebral mapping in awake craniotomy. Practical considerations Neurochirurgie 63:164–174. https://doi.org/10.1016/j.neuchi.2016.08.009

Article  CAS  PubMed  Google Scholar 

Pallud J, Mandonnet E, Corns R et al (2017) Technical principles of direct bipolar electrostimulation for cortical and subcortical mapping in awake craniotomy. Neurochirurgie 63:158–163. https://doi.org/10.1016/j.neuchi.2016.12.004

Article  CAS  PubMed  Google Scholar 

Elia A, Young JS, Simboli GA et al (2023) A Preoperative Scoring System to Predict Function-Based Resection Limitation Due to Insufficient Participation During Awake Surgery. Neurosurgery 93:678–690. https://doi.org/10.1227/neu.0000000000002477

Article  PubMed  Google Scholar 

Zanello M, Roux A, Zah-Bi G et al (2020) Predictors of early postoperative epileptic seizures after awake surgery in supratentorial diffuse gliomas. J Neurosurg 134:683–692. https://doi.org/10.3171/2020.1.JNS192774

Article  PubMed  Google Scholar 

Pallud J, Roux A, Trancart B et al (2021) Surgery of Insular Diffuse Gliomas-Part 2: Probabilistic Cortico-Subcortical Atlas of Critical Eloquent Brain Structures and Probabilistic Resection Map During Transcortical Awake Resection. Neurosurgery 89:579–590. https://doi.org/10.1093/neuros/nyab255

Article  PubMed  Google Scholar 

Herbet G, Rigaux-Viodé O, Moritz-Gasser S (2017) Peri- and intraoperative cognitive and language assessment for surgical resection in brain eloquent structures. Neurochirurgie 63:135–141. https://doi.org/10.1016/j.neuchi.2016.10.011

Article  CAS  PubMed  Google Scholar 

Roux A, Dezamis E, Trancart B, Pallud J (2020) How I do it: trans-cortical approach for insular diffuse glioma. Acta Neurochir (Wien) 162:3025–3030. https://doi.org/10.1007/s00701-020-04553-w

Article  PubMed  Google Scholar 

Pallud J, Capelle L, Taillandier L et al (2009) Prognostic significance of imaging contrast enhancement for WHO grade II gliomas. Neuro Oncol 11:176–182. https://doi.org/10.1215/15228517-2008-066

Article  PubMed  Google Scholar 

Pallud J, Zanello M, Moiraghi A et al (2021) Surgery of Insular Diffuse Gliomas-Part 1: Transcortical Awake Resection Is Safe and Independently Improves Overall Survival. Neurosurgery 89:565–578. https://doi.org/10.1093/neuros/nyab254

Article  PubMed  Google Scholar 

Wu AS, Witgert ME, Lang FF et al (2011) Neurocognitive function before and after surgery for insular gliomas. J Neurosurg 115:1115–1125. https://doi.org/10.3171/2011.8.JNS11488

Article  PubMed  Google Scholar 

Baker CM, Burks JD, Briggs RG et al (2018) A Connectomic Atlas of the Human Cerebrum—Chapter 1: Introduction, Methods, and Significance. Oper Neurosurg 15:S1–S9. https://doi.org/10.1093/ons/opy253

Article  PubMed  PubMed Central  Google Scholar 

Wen PY, van den Bent M, Youssef G et al (2023) RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults. J Clin Oncol 4